Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties
Alana Gomes de Souza, Adriano José Maia Chaves Filho, João Victor Souza Oliveira, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 429-439
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy
Krzysztof Łukawski, Stanisław J. Czuczwar
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1049-1049
Open Access | Times Cited: 50
Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders
Christian Hölscher
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 695-714
Open Access | Times Cited: 98
Levetiracetam Mechanisms of Action: From Molecules to Systems
Itzel Jatziri Contreras‐García, Noemí Cárdenas‐Rodríguez, Antonio Romo‐Mancillas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 475-475
Open Access | Times Cited: 69
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability
Tanveer Singh, Awanish Mishra, Rajesh Kumar Goel
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1573-1590
Closed Access | Times Cited: 67
Sodium butyrate ameliorates mitochondrial oxidative stress and alterations in membrane-bound enzyme activities in pentylenetetrazole-induced kindling rat model
Olusegun L. Adebayo, Gbemileke Emmanuel Luro, Ifewunmi Deborah Akeju, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Closed Access | Times Cited: 1
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Jan Detka, Katarzyna Głombik
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 47
GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
Meltem Dönmez Kutlu, Seda Köse, Kübra Akıllıoğlu
Behavioural Brain Research (2023) Vol. 445, pp. 114386-114386
Closed Access | Times Cited: 17
Impact of levetiracetam on cognitive impairment, neuroinflammation, oxidative stress, and neuronal apoptosis caused by lipopolysaccharides in rats
Vasudevan Mani, Salem Rashed Almutairi
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101728-101728
Open Access | Times Cited: 17
Cognition and memory impairment attenuation via reduction of oxidative stress in acute and chronic mice models of epilepsy using antiepileptogenic Nux vomica
Priya Mishra, Amit Mittal, Satyendra Kumar Rajput, et al.
Journal of Ethnopharmacology (2020) Vol. 267, pp. 113509-113509
Closed Access | Times Cited: 43
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
Lucia Caffino, Francesca Mottarlini, Fabio Fumagalli
CNS Drugs (2020) Vol. 34, Iss. 3, pp. 281-297
Open Access | Times Cited: 42
Neuroprotective role of chrysin‐loaded poly(lactic‐co‐glycolic acid) nanoparticle against kindling‐induced epilepsy through Nrf2/ARE/HO‐1 pathway
Ying Zhang, Jing Zhao, Obaid Afzal, et al.
Journal of Biochemical and Molecular Toxicology (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 42
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?
Wolfgang Löscher, Pavel Klein
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107934-107934
Open Access | Times Cited: 40
Combination of levetiracetam with sodium selenite prevents pentylenetetrazole-induced kindling and behavioral comorbidities in rats
Zohabia Rehman, Talha Bin Farooq, Sana Javaid, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 5, pp. 494-507
Open Access | Times Cited: 28
Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway
Mohamed A. Sadek, Esraa A. Kandil, Nesrine S. El Sayed, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109647-109647
Closed Access | Times Cited: 26
Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2/HO-1 antioxidant and inhibiting NF-κB, proinflammatory cytokines and iNOS/NO pathways
Keyvan Amirshahrokhi, Mahsa Imani
International Immunopharmacology (2023) Vol. 119, pp. 110165-110165
Closed Access | Times Cited: 14
The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases
Longqing Zhang, Wen Zhang, Xuebi Tian
International Journal of Neuroscience (2021) Vol. 133, Iss. 5, pp. 473-491
Closed Access | Times Cited: 28
Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities
Mohammad Amin Manavi
Neuropeptides (2022) Vol. 94, pp. 102250-102250
Closed Access | Times Cited: 22
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis
Rita Citraro, Michelangelo Iannone, Antonio Leo, et al.
Brain Research Bulletin (2019) Vol. 153, pp. 133-142
Open Access | Times Cited: 31
The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder
Adriano José Maia Chaves Filho, Natássia Lopes Cunha, Alana Gomes de Souza, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109872-109872
Closed Access | Times Cited: 31
Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS
Gagandeep Jaiswal, Puneet Kumar
Behavioural Brain Research (2021) Vol. 419, pp. 113699-113699
Closed Access | Times Cited: 26
Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
Zijuan Zhang, Hai Li, Yunfang Su, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
Empagliflozin Mitigates PTZ-Induced Seizures in Rats: Modulating Npas4 and CREB-BDNF Signaling Pathway
Heba A. Abdelaziz, Mohamed F. Hamed, Hamdy A. Ghoniem, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
In silico and in vivo evaluation of erucic acid against pentylenetetrazole-induced seizures in mice by modulating oxidative stress, neurotransmitters and neuroinflammation markers
Sami I. Alzarea, Muhammad Afzal, Ehssan Moglad, et al.
Nutritional Neuroscience (2025), pp. 1-16
Closed Access
Leonurine Attenuates Neuroinflammation and Oxidative Stress in a Pentylenetetrazole-induced Epilepsy in Rats
Hua Hui, Fan Li
Pharmacognosy Magazine (2025)
Open Access
Page 1 - Next Page

Scroll to top